세계의 의약품 유리 포장 시장 : 제품 유형, 재료 유형, 용도, 지역별 예측(-2032년)

Global Pharmaceutical Glass Packaging Market Research Report Information by Product Type (Vials, Bottles & Jars, Cartridges & Syringes, Ampoules), by Material Type (Type I, Type II, Type III), by Application (Generic Drugs, Branded Drugs, Biological Drugs), and by Region (North America, Europe, Asia-Pacific, Middle East & Africa, and South America) Market Forecast Till 2032

Market Overview

In 2023, the pharmaceutical glass packaging market was estimated to be worth USD 21,354.2 million. The Global Pharmaceutical Glass Packaging industry is anticipated to experience a compound annual growth rate (CAGR) of 7.3% from USD 22,913.06 Million in 2024 to USD 40,409.6 Million by 2032.

The Pharmaceutical Glass Packaging Market is being led by the expansion of the pharmaceutical industry in emerging economies, the growing demand for pharmaceutical items to be extended, and the growing emphasis on anti-counterfeiting measures.

The Pharmaceutical Glass Packaging Market is being bolstered by the growing pharmaceutical industry in emerging economies and the heightened emphasis on anti-counterfeiting measures.

Market segment insights

The market is segmented into four categories: vials, bottles and canisters, cartridges and syringes, and ampoules, based on the type of product.

The market is segmented into type I, type II, and type III according to the type of material.

Generic drugs, branded drugs, and biological drugs comprise the application segment of the Pharmaceutical Glass Packaging Market size.

Regional Perspectives

The study offers market insights into North America, Europe, Asia-Pacific, Middle East & Africa, and South America by region. In 2023, the North American pharmaceutical glass packaging market held the largest market share and is anticipated to experience a substantial CAGR growth during the research period. The pharmaceutical glass packing sector in North America will experience development in the future due to the increase in funding to produce conventional medicines. The government's emphasis on the development of long-term drugs for chronic diseases is expected to drive the evolution of the pharmaceutical glass packaging market in the sub-continent. It is anticipated that the revenue of the regional market will be significantly increased over the next decade because of the presence of major participants in the region.

Additionally, Asia Pacific is the second-largest region in the Pharmaceutical Glass Packaging Market. The markets are further augmented by the increasing technological advancements in the glass packaging of medications, which are resulting in advanced uses. The demand for glass packaging is expected to increase swiftly in India, a prominent and expanding market for medications.

Furthermore, the pharmaceutical glass packaging market in Europe has experienced substantial growth in recent years. The financial system of Europe is most notable for its pharmaceutical manufacturing, which is founded on research. The escalation in medicinal development, which is characterized by the exploration, expansion, and presentation of innovative medications aimed at improving the physical condition and quality of life of patients in the region, is resulting in an increase in the production of pharmaceutical glass packaging.

Major Players

Gerresheimer AG, Nipro Corporation, Schott Pharmaceutical Packaging, Stevanato Group, Bormioli Pharma S.P.A, West Pharmaceutical Services, Inc, PGP Glass, Stolzle-Oberglas Gmbh, Arab Pharmaceutical Glass Co, and Ajanta Bottle are among the main players in the market.

TABLE OF CONTENTS

1 EXECUTIVE SUMMARY

2 MARKET INTRODUCTION

• 2.1 DEFINITION
• 2.2 SCOPE OF THE STUDY
• 2.3 RESEARCH OBJECTIVE
• 2.4 MARKET STRUCTURE

3 RESEARCH METHODOLOGY

• 3.1 OVERVIEW
• 3.2 DATA FLOW
  • 3.2.1 DATA MINING PROCESS
• 3.3 PURCHASED DATABASE:
• 3.4 SECONDARY SOURCES:
  • 3.4.1 SECONDARY RESEARCH DATA FLOW:
• 3.5 PRIMARY RESEARCH:
  • 3.5.1 PRIMARY RESEARCH DATA FLOW:
  • 3.5.2 PRIMARY RESEARCH: NUMBER OF INTERVIEWS CONDUCTED
  • 3.5.3 PRIMARY RESEARCH: REGIONAL COVERAGE
• 3.6 APPROACHES FOR MARKET SIZE ESTIMATION:
  • 3.6.1 REVENUE ANALYSIS APPROACH
• 3.7 DATA FORECASTING
  • 3.7.1 DATA FORECASTING TECHNIQUE
• 3.8 DATA MODELING
  • 3.8.1 MICROECONOMIC FACTOR ANALYSIS:
  • 3.8.2 DATA MODELING:
• 3.9 TEAMS AND ANALYST CONTRIBUTION

4 MARKET DYNAMICS

• 4.1 INTRODUCTION
• 4.2 DRIVERS
  • 4.2.1 GROWTH OF THE PHARMACEUTICAL INDUSTRY IN EMERGING ECONOMIES
  • 4.2.2 INCREASING DEMAND FOR EXTENDING THE SHELF LIFE OF PHARMACEUTICAL ITEMS
• 4.3 RESTRAINTS
  • 4.3.1 INCREASING ADOPTION OF ALTERNATIVE PACKAGING MATERIALS
• 4.4 OPPORTUNITY
  • 4.4.1 INCREASING FOCUS ON ANTI-COUNTERFEITING MEASURES
  • 4.4.2 UTILIZING NEW TYPES OF GLASS TO REDUCE PRODUCT CONTAMINATION
• 4.5 COVID-19 IMPACT ANALYSIS
  • 4.5.1 IMPACT ON OVERALL PACKAGING INDUSTRY
    • 4.5.1.1 ECONOMIC IMPACT
  • 4.5.2 IMPACT ON THE OVERALL PACKAGING INDUSTRY
  • 4.5.3 IMPACT ON SUPPLY CHAIN OF PHARMACEUTICAL GLASS PACKAGING
    • 4.5.3.1 PRICE VARIATION OF KEY RAW MATERIALS
    • 4.5.3.2 PRODUCTION SHUTDOWN
    • 4.5.3.3 CASH FLOW CONSTRAINTS
    • 4.5.3.4 IMPACT ON IMPORT/EXPORT
  • 4.5.4 IMPACT ON MARKET DEMAND OF PHARMACEUTICAL GLASS PACKAGING
    • 4.5.4.1 IMPACT DUE TO RESTRICTIONS/LOCKDOWN
    • 4.5.4.2 CONSUMER SENTIMENTS.
  • 4.5.5 IMPACT ON PRICING OF PHARMACEUTICAL GLASS PACKAGING

5 MARKET FACTOR ANALYSIS

• 5.1 SUPPLY CHAIN ANALYSIS
  • 5.1.1 RAW MATERIAL SUPPLY
  • 5.1.2 MANUFACTURING
  • 5.1.3 QUALITY CONTROL AND ASSURANCE
  • 5.1.4 DISTRIBUTION CHANNELS
  • 5.1.5 END USERS
• 5.2 PORTER'S FIVE FORCES MODEL
  • 5.2.1 THREAT OF NEW ENTRANTS
  • 5.2.2 BARGAINING POWER OF SUPPLIERS
  • 5.2.3 THREAT OF SUBSTITUTES
  • 5.2.4 BARGAINING POWER OF BUYERS
  • 5.2.5 INTENSITY OF RIVALRY

6 GLOBAL PHARMACEUTICAL GLASS PACKAGING MARKET, BY PRODUCT TYPE

• 6.1 OVERVIEW
• 6.2 VIALS
• 6.3 BOTTLES & JARS
• 6.4 CARTRIDGES & SYRINGES
• 6.5 AMPOULES

7 GLOBAL PHARMACEUTICAL GLASS PACKAGING MARKET, BY MATERIAL TYPE

• 7.1 INTRODUCTION
• 7.2 TYPE I
• 7.3 TYPE II
• 7.4 TYPE III

8 GLOBAL PHARMACEUTICAL GLASS PACKAGING MARKET, BY APPLICATION

• 8.1 INTRODUCTION
• 8.2 GENERIC DRUGS
• 8.3 BRANDED DRUGS
• 8.4 BIOLOGICAL DRUGS

9 GLOBAL PHARMACEUTICAL GLASS PACKAGING MARKET, BY REGION

• 9.1 OVERVIEW
  • 9.1.1 GLOBAL PHARMACEUTICAL GLASS PACKAGING MARKET, BY REGION, 2022 VS 2032 (USD MILLION)
  • 9.1.2 GLOBAL PHARMACEUTICAL GLASS PACKAGING MARKET, BY REGION, 2018-2032 (USD MILLION)
• 9.2 NORTH AMERICA
  • 9.2.1 US
  • 9.2.2 CANADA
  • 9.2.3 MEXICO
• 9.3 EUROPE
  • 9.3.1 GERMANY
  • 9.3.2 FRANCE
  • 9.3.3 UK
  • 9.3.4 ITALY
  • 9.3.5 SPAIN
  • 9.3.6 REST OF EUROPE
• 9.4 ASIA-PACIFIC
  • 9.4.1 CHINA
  • 9.4.2 INDIA
  • 9.4.3 JAPAN
  • 9.4.4 SOUTH KOREA
  • 9.4.5 REST OF ASIA PACIFIC
• 9.5 MIDDLE EAST & AFRICA
  • 9.5.1 SAUDI ARABIA
  • 9.5.2 SOUTH AFRICA
  • 9.5.3 UAE
  • 9.5.4 REST OF MIDDLE EAST & AFRICA
• 9.6 SOUTH AMERICA
  • 9.6.1 BRAZIL
  • 9.6.2 ARGENTINA
  • 9.6.3 REST OF SOUTH AMERICA

10 COMPETITIVE LANDSCAPE

• 10.1 INTRODUCTION
• 10.2 COMPETITOR DASHBOARD
• 10.3 COMPANY MARKET SHARE ANALYSIS,
• 10.4 PUBLIC PLAYERS STOCK SUMMARY
• 10.5 COMPARATIVE ANALYSIS: KEY PLAYERS FINANCIAL
• 10.6 LIST OF KEY PLAYERS BY REGION
• 10.7 KEY DEVELOPMENTS & GROWTH STRATEGIES
  • 10.7.1 NEW PRODUCT LAUNCH/ DEVELOPMENT
  • 10.7.2 MERGER & ACQUISITION
  • 10.7.3 PARTNERSHIP/COLLABORATION, INVESTMENT, EXPANSION, AND OTHERS

11 COMPANY PROFILES

• 11.1 GERRESHEIMER AG
  • 11.1.1 COMPANY OVERVIEW
  • 11.1.2 FINANCIAL OVERVIEW
  • 11.1.3 PRODUCTS OFFERED
  • 11.1.4 KEY DEVELOPMENTS
  • 11.1.5 SWOT ANALYSIS
  • 11.1.6 KEY STRATEGIES:
• 11.2 NIPRO CORPORATION
  • 11.2.1 COMPANY OVERVIEW
  • 11.2.2 FINANCIAL OVERVIEW
  • 11.2.3 PRODUCTS OFFERED
  • 11.2.4 KEY DEVELOPMENTS
  • 11.2.5 SWOT ANALYSIS
  • 11.2.6 KEY STRATEGIES
• 11.3 SCHOTT PHARMACEUTICAL PACKAGING
  • 11.3.1 COMPANY OVERVIEW
  • 11.3.2 FINANCIAL OVERVIEW
  • 11.3.3 PRODUCTS OFFERED
  • 11.3.4 KEY DEVELOPMENTS
  • 11.3.5 SWOT ANALYSIS
  • 11.3.6 KEY STRATEGIES
• 11.4 STEVANATO GROUP.
  • 11.4.1 COMPANY OVERVIEW
  • 11.4.2 FINANCIAL OVERVIEW
  • 11.4.3 PRODUCTS OFFERED
  • 11.4.4 KEY DEVELOPMENTS
  • 11.4.5 SWOT ANALYSIS
  • 11.4.6 KEY STRATEGIES
• 11.5 BORMIOLI PHARMA S.P.A.
  • 11.5.1 COMPANY OVERVIEW
  • 11.5.2 FINANCIAL OVERVIEW
  • 11.5.3 PRODUCTS OFFERED
  • 11.5.4 KEY DEVELOPMENTS
  • 11.5.5 SWOT ANALYSIS
  • 11.5.6 KEY STRATEGIES
• 11.6 WEST PHARMACEUTICAL SERVICES, INC.
  • 11.6.1 COMPANY OVERVIEW
  • 11.6.2 FINANCIAL OVERVIEW
  • 11.6.3 PRODUCTS OFFERED
  • 11.6.4 KEY DEVELOPMENTS
  • 11.6.5 SWOT ANALYSIS
  • 11.6.6 KEY STRATEGIES
• 11.7 PGP GLASS
  • 11.7.1 COMPANY OVERVIEW
  • 11.7.2 FINANCIAL OVERVIEW
  • 11.7.3 PRODUCTS OFFERED
  • 11.7.4 KEY DEVELOPMENTS
  • 11.7.5 SWOT ANALYSIS
  • 11.7.6 KEY STRATEGIES
• 11.8 STOLZLE-OBERGLAS GMBH
  • 11.8.1 COMPANY OVERVIEW
  • 11.8.2 FINANCIAL OVERVIEW
  • 11.8.3 PRODUCTS OFFERED
  • 11.8.4 KEY DEVELOPMENTS
  • 11.8.5 SWOT ANALYSIS
  • 11.8.6 KEY STRATEGIES
• 11.9 ARAB PHARMACEUTICAL GLASS CO.
  • 11.9.1 COMPANY OVERVIEW
  • 11.9.2 FINANCIAL OVERVIEW
  • 11.9.3 PRODUCTS OFFERED
  • 11.9.4 KEY DEVELOPMENTS
  • 11.9.5 SWOT ANALYSIS
  • 11.9.6 KEY STRATEGIES
• 11.10 AJANTA BOTTLE
  • 11.10.1 COMPANY OVERVIEW
  • 11.10.2 FINANCIAL OVERVIEW
  • 11.10.3 PRODUCTS OFFERED
  • 11.10.4 KEY DEVELOPMENTS
  • 11.10.5 SWOT ANALYSIS
  • 11.10.6 KEY STRATEGIES
• 11.11 DATA CITATIONS